Cell cultures, whether or not modified; cell therapy products

300251 (Harmonized System 2022 for 6-digit)

About

Overview This page contains the latest trade data of Cell therapy products. In 2022, Cell therapy products were the world's 2895th most traded product, with a total trade of $638M.

Cell therapy products are a part of Vaccines, blood, antisera, toxins and cultures.

Exports In 2022 the top exporters of Cell therapy products  were United States ($251M), Germany ($105M), Netherlands ($82.8M), Switzerland ($62.4M), and United Kingdom ($59.3M).

Imports In 2022 the top importers of Cell therapy products were Germany ($102M), United States ($90.2M), Netherlands ($56.7M), Japan ($54.2M), and United Kingdom ($47.4M).

Ranking Cell therapy products ranks 137th in the Product Complexity Index (PCI).

Latest Data

View
Flow
Y-AXIS SCALE

The following visualization shows the latest trends on Cell therapy products. Countries are shown based on data availability.

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

Explore Latest Trends

* Trade values are converted to USD using each month's exchange rate. For December 2023 data, the exchange rate from December 30, 2023 is used.

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Exporters and Importers

Top Origin (2022)United States$251M
Top Destination (2022)Germany$102M

In 2022 Cell therapy products were the world's 2895th most traded product (out of 5,606).

In 2022, the top exporters of Cell therapy products were United States ($251M), Germany ($105M), Netherlands ($82.8M), Switzerland ($62.4M), and United Kingdom ($59.3M).

In 2022, the top importers of Cell therapy products were Germany ($102M), United States ($90.2M), Netherlands ($56.7M), Japan ($54.2M), and United Kingdom ($47.4M).

Explore Visualizations

Exporters of Cell therapy products (2022)
[Click to Select a Country]

Importers of Cell therapy products (2022)
[Click to Select a Country]

Market Dynamics

Color
Top Origin Growth (false -  2022)United States$251M
Top Destination Growth (false -  2022)Germany$102M

Between false and 2022, the exports of Cell therapy products grew the fastest in United States ($251M), Germany ($105M), Netherlands ($82.8M), Switzerland ($62.4M), and United Kingdom ($59.3M).

Between false and 2022, the fastest growing importers of Cell therapy products were Germany ($102M), United States ($90.2M), Netherlands ($56.7M), Japan ($54.2M), and United Kingdom ($47.4M).

Explore Visualizations

Exporters of Cell therapy products (NaN - 2022)

Importers of Cell therapy products (NaN - 2022)

Net Trade

TOP NET EXPORTER (2022)United States$161M
TOP NET IMPORTER (2022)Japan$53.5M

This map shows which countries export or import more of Cell therapy products. Each country is colored based on the difference in exports and imports of Cell therapy products during 2022.

In 2022, the countries that had a largest trade value in exports than in imports of Cell therapy products were United States ($161M), Switzerland ($50.5M), Netherlands ($26.2M), Ireland ($17M), and United Kingdom ($11.9M).

In 2022, the countries that had a largest trade value in imports than in exports of Cell therapy products were Japan ($53.5M), Canada ($35.7M), South Korea ($23.4M), Czechia ($20.5M), and Italy ($18.8M).

Net Trade (2022)

Product Complexity

Diversification Frontier

Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.

Relatedness vs Country Complexity (2022)

Have questions, comments, or concerns?
Send us an e-mail: [email protected]
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with